Search form

Latest News

Quidel Receives Preliminary Contract Leading to Definitive Agreement for $71 Million Under NIH’s RADx-ATP Program to Accelerate the Expansion of Its Manufacturing Capacity for Sofia® SARS-CoV-2 Antigen Detection Test for Rapid Diagnosis of COVID-19

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has entered into a preliminary letter contract with the National Institute...

Read More »


To place orders, get assistance with shipments, pricing or contract administration view our Customer Support page.

Visit our Technical Support page to get help with product specifications, supporting docs or general support issues.

For Package Inserts and supporting docs visit our Document Search Tool

NEW: Visit for help connecting your Quidel Instruments to the cloud, including the Virena surveillance system.

Register at to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments.

By continuing to use this site you are agreeing to our use of cookies. For more details please see our Privacy and Cookie Notice.